Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer

British Journal of Cancer
P DettmarH Höfler

Abstract

MIB1 proliferation rate (MIB1-PR) and total S-phase fraction (SPF) were retrospectively determined in formalin-fixed, paraffin-embedded sections of 90 primary node-negative breast carcinomas. None of the patients had received adjuvant systemic therapy. Median follow-up in patients still alive at the time of analysis was 37.5 months (16-72 months). Immunostaining of Ki-67 antigen was performed using the monoclonal antibody MIB1 and the APAAP technique. An adjacent 50-microm paraffin section was used for flow cytometric S-phase determination. Results were compared to established clinicopathological prognostic factors. MIB1-PR was significantly correlated to grading (P = 0.018); SPF was significantly correlated with tumour size (P = 0.041) and inversely with steroid hormone receptor status (P = 0.03). A significant correlation between MIB1-PR and SPF was found in aneuploid (P = 0.025) but not in diploid tumours (P = 0.164). In univariate analysis, both MIB1-PR (optimized cut-off of 25%) and SPF (optimized cut-off of 8%) were significant prognostic factors for disease-free survival (DFS) (MIB1-PR, P = 0.0224; SPF, P = 0.0028). In multivariate analysis, however, only SPF remained significant; it was the strongest prognostic factor f...Continue Reading

Citations

Feb 19, 1999·Journal of Clinical Pathology·P J van DiestJ P Baak
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H B SalvesenL A Akslen
Sep 21, 2000·The Journal of Clinical Investigation·M G CangiM Loda
Aug 24, 2000·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·M BriffodV Le Doussal
Jan 5, 2002·Journal of the National Cancer Institute. Monographs·M G Daidone, R Silvestrini
Jun 18, 2004·Cancer Investigation·Juan R De la Haba-RodríguezEnrique Aranda Aguilar
Mar 19, 2009·British Journal of Cancer·K AaltonenC Blomqvist
Aug 28, 2009·International Journal of Cancer. Journal International Du Cancer·Mohammed A AleskandaranyIan O Ellis
Sep 13, 2013·Histopathology·Chih-Yi HsuDonald Ming-Tak Ho
Mar 12, 1998·International Journal of Cancer. Journal International Du Cancer·S RozanX Sastre-Garau
Jun 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P BroëtF Spyratos
Feb 1, 2000·Journal of Cellular Physiology·T Scholzen, J Gerdes
Mar 21, 2002·Histopathology·D C Brown, K C Gatter
Nov 20, 2004·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Yasuhiro ItoAkira Miyauchi
Dec 5, 2006·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mikael RailoStig Nordling
Jun 23, 2010·Clinical Medicine Insights. Oncology·Pankaj TanejaKazushi Inoue
Mar 10, 1999·British Journal of Cancer·R L HuuhtanenL C Andersson
Mar 6, 1999·Breast Cancer Research and Treatment·C R Wenger, G M Clark
Feb 26, 1999·Journal of the National Cancer Institute·P RudolphR Parwaresch
Mar 10, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·D PrechtelA K Werenskiold
Dec 8, 2000·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·P HantschmannR Kurzl
Jun 26, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Charles DumontetJohn C Reed
Mar 15, 2003·Clinical Breast Cancer·Alessandro MorabitoGiampietro Gasparini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.